Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:e65
Published online before print June 21, 2007, doi: 10.1161/STROKEAHA.107.485615
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/8/e65    most recent
STROKEAHA.107.485615v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zoppo, A.
Right arrow Articles by Baggi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoppo, A.
Right arrow Articles by Baggi, L.

(Stroke. 2007;38:e65.)
© 2007 American Heart Association, Inc.


Letters to the Editor

Underestimate Psychological Impact of Diet Intervention

Adele Zoppo, MD, PhD; Carmela Asteria, MD, PhD; Francesca Podesta, MD, PhD Laura Baggi

MultiMedica, Milan, Italy

To the Editor:

We read with interest the paper by Salaycik et al,1 in which depressive symptoms are an independent risk factor for incident stroke/TIA in individuals younger than age 65 years. According to NCEP ATP III,2 changes in eating patterns are still central to the treatment and prevention of cardiovascular and cerebrovascular risk. An aggressive dietary intervention costs significantly less than drug treatment and side effects are virtually absent.3 However, what about the psychological impact of diet? It is well known that adherence to diet is usually the most difficult endpoint to obtain on the long-term because of the intense psychological endeavor in changing food habits.

To evaluate the psychological reaction to an educational and diet intervention program, 126 hyperlipidemic outpatients, with high cardiovascular risk, have been provided alimentary suggestions or diet regimen according to the model of Therapeutic Lifestyle Changes.4 Patients were classified, according to their BMI, in 3 groups (normal n=50: BMI, 22.58±0.20; overweight n=22: BMI, 25.92±0.17; obese n=54: BMI, 30.62±0.42) and were evaluated by a psychologist before and after 18 weeks of diet treatment. The Minnesota Multiphasic Personality Inventory test5 was used to assess the effectiveness of the educational treatment (to verify compliance to diet) and its psychological risks (eg, rejection of disease condition). After 18 weeks, statistically significant weight loss was obtained in both the groups of obese patients (BMI, 30.62±0.42 versus 29.31±0.54; mean±SD, P<0.04) and overweight subjects (BMI, 25.92±0.17 versus 24.87±1.44; P<0.001). No weight variation was observed in the normal BMI group. The 3 groups reached the prefixed endpoint for lipid profile. The Minnesota Multiphasic Personality Inventory test identified 4 classes of emotional disorder risk (score 1 to 2, none or partial risk; score 3 to 4, medium or high risk). In the normal and obese groups, respectively, 36% and 40% of subjects showed score 3 to 4 compared with 11% in the overweight group.

In conclusion, our data suggest that subjects with normal BMI but hyperlipidemic, as well as obese patients, are challenged by the diet therapy with a higher psychological disorder risk when compared with overweight patients, irrespectively of reaching the lipid endpoint and cardiovascular risk reduction. It is necessary to develop, besides drug prescription, simple and individualized strategies for hyperlipidemic patients, mainly for patients with normal BMI that often show severe familiar hyperlipidemia.

Acknowledgments

Disclosures

None.

References

1. Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen AH, Brady SM, Kase CS, Wolf PA. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007; 38: 16–21.[Abstract/Free Full Text]

2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III final report). Circulation. 2002; 106: 3143–3421.[Free Full Text]

3. Denke MA. Diet, lifestyle, and nonstatin trials: review of time to benefit. Am J Cardiol. 2005; 96: 3F–10F.[Medline] [Order article via Infotrieve]

4. Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel III Update: adjustment and options. Am J Cardiol. 2005; 96: 53E–59E.[Medline] [Order article via Infotrieve]

5. Simms LJ, Casillas A, Clark LA, Watson D, Doebbeling BN. Psychometric evaluation of the restructured clinical scales of the MMPI-2. Psychol Assess. 2005; 17: 345–358.[CrossRef][Medline] [Order article via Infotrieve]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/8/e65    most recent
STROKEAHA.107.485615v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zoppo, A.
Right arrow Articles by Baggi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoppo, A.
Right arrow Articles by Baggi, L.